Jeena Sikho Lifecare

Jeena Sikho Lifecare delivered a stellar Q3 FY26 with revenue of ₹221.7 croreCurrent reported value: ₹221.7 crore. No comparable prior figure is available in the source record. (+92Current reported value: 92. No comparable prior figure is available in the source record.% YoY), EBITDA of ₹100.8 croreCurrent reported value: ₹100.8 crore. No comparable prior figure is available in the source record. (+240% YoY), and PAT of ₹66.7 croreCurrent reported value: ₹66.7 crore. No comparable prior figure is available in the source record. (+405Current reported value: 405. No comparable prior figure is available in the source record.% YoY). EBITDA margin held at 45%Current reported value: 45%. No comparable prior figure is available in the source record. despite aggressive expansion. The strong performance was driven by a 247% surge in OPD/COD patients to 4.34 lakhCurrent 4.34 lakh. Reported change: +247% YoY. and robust product sales, including the OTC 'Pet Yakrit Plia Shuddhi Kit' crossing ₹10 crore monthly. Management guided for 7,000-10,000 beds over 3-5 years (currently ~2,800), a new health card launch, and 16 OTC products by year-end. A key risk is the slow government portal rollout, which management is de-emphasizing in favor of private and insurance business.